IP Library Granted Patent US 11,077,246
Granted Patent B2
US 11,077,246 · App. 16/049,850 · Granted Aug 3, 2021

Wearable injector with sterile adhesive patch

Inventors: Ali Nekouzadeh (Simi Valley, CA); Jerome Olivas (Thousand Oaks, CA); Joshua Merilos (Thousand Oaks, CA); Matthew Wayne Janke (Simi Valley, CA); Justin Harris (Reseda, CA); Marc Orloff (Calabasas, CA); Edward Stapleford Nielsen (Ventura, CA); Chitra Nadig (Chatsworth, CA); Yasaman Damestani (Thousand Oaks, CA); Guojie Song (Moorpark, CA); Bryton De Guia (Newbury Park, CA)
Assignee: AMGEN INC.
A61M5/14248A61M5/20A61M2005/14252A61M2005/14264A61M2205/0205A61M2205/0238A61M2205/50A61M2205/58A61M2205/587
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,077,246
App. No.
16/049,850
Granted
Aug 3, 2021
Kind
B2
Abstract

An adhesive patch for a drug delivery device with a bacteria impermeable sterility margin surrounding an edge surface of the adhesive patch is disclosed, as well as a drug delivery device fixed to such an adhesive patch and a method of assembling a drug delivery device with such an adhesive patch. In some arrangements, the sterility margin is attached to or integral with a lower liner on a lower surface of the adhesive patch. In other arrangements, the sterility margin is attached to or integral with an upper liner on an upper surface of the adhesive patch.

Claims (21)

1. A drug delivery device comprising:

a housing having a bottom wall;

an adhesive patch adhered to the bottom wall and having an area contained within an outer perimeter, the area having an upper surface, a lower surface, and an edge surface at the outer perimeter between the upper surface and the lower surface;

a bacteria impermeable lower liner on the lower surface; and

a bacteria impermeable sterility margin surrounding and abutting the edge surface of the adhesive patch,

wherein the outer perimeter of the adhesive patch is pre-cut to separate from the sterility margin.

2. The drug delivery device of claim 1 , wherein the bacteria impermeable sterility margin is attached to or integral with the adhesive patch or the lower liner.

3. The drug delivery device of claim 1 , further comprising a bacteria impermeable upper liner on the upper surface, wherein the sterility margin is optionally attached to or integral with the upper liner.

4. The drug delivery device of claim 1 , wherein the outer perimeter of the adhesive patch is pre-cut in a perforated manner to separate from the sterility margin.

5. The drug delivery device of claim 1 , wherein the housing includes an interior space and a top wall, a container is disposed within the interior space, and the top wall includes a window positioned to allow viewing of the container, the window including a polarized filter that filters out up to and including 50% of light in the visible range.

6. An adhesive system for use with a wearable drug delivery device, the system comprising:

an adhesive patch having an outer perimeter, an upper surface, a lower surface, and an edge surface at the outer perimeter and extending between the upper surface and the lower surface;

a bacteria impermeable lower liner on the lower surface; and

a bacteria impermeable sterility margin surrounding and abutting the edge surface of the adhesive patch,

wherein the outer perimeter of the adhesive patch is pre-cut to separate from the sterility margin.

7. The adhesive system of claim 6 , wherein the bacteria impermeable sterility margin is attached to or integral with the adhesive patch or the lower liner.

8. The adhesive system of claim 6 , further comprising a bacteria impermeable upper liner on the upper surface, wherein the sterility margin is optionally attached to or integral with the upper liner.

9. The adhesive system of claim 8 , wherein the upper liner includes a pre-cut first perimeter surrounding a portion of an area of the adhesive patch that is configured to be adhered to a drug delivery device.

10. The adhesive system of claim 6 , further comprising a hole provided in the area to allow passage of a delivery member of the drug delivery device.

11. The adhesive system of claim 6 , wherein the outer perimeter is pre-cut in a perforated manner to separate from the sterility margin.

12. The adhesive system of claim 6 , wherein the sterility margin has a width of at least two millimeters.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2019
From: NEKOUZADEH, ALI; OLIVAS, JEROME; MERILOS, JOSHUA; JANKE, MATTHEW WAYNE; HARRIS, JUSTIN; ORLOFF, MARC; NIELSEN, EDWARD STAPLEFORD; NADIG, CHITRA; DAMESTANI, YASAMAN; SONG, GUOJIE; DE GUIA, BRYTON
To: AMGEN INC.
Reel/Frame 050369/0946 →
Continuity (2)
Provisional Application 62547500 · Aug 18, 2017
Related Publication 20190083702A1 · Mar 21, 2019
Cited By (4)
US 1,122,440 US 12,226,613 US 12,533,298 US 12,691,213